Coccidiosis

Coccidiosis is a common protozoal infection affecting the intestinal tract of dogs and cats, caused by various species of the phylum Apicomplexa, primarily of the genera Cystoisospora (formerly Isospora) in dogs and cats, and less commonly Cryptosporidium, Eimeria, and Hammondia. The disease is characterized by enteritis, diarrhea, and malabsorption, particularly in young, stressed, or immunocompromised animals. Coccidia are obligate intracellular parasites that undergo both asexual (merogony) and sexual (gametogony) reproduction within the intestinal epithelium, leading to epithelial destruction, villous atrophy, and mucosal inflammation. The severity of clinical disease ranges from subclinical shedding to severe hemorrhagic diarrhea, dehydration, and death, especially in neonates. Coccidiosis is a significant cause of morbidity in kennels, shelters, and catteries, and is often a component of the feline and canine enteric disease complex.

The primary etiological agents of coccidiosis in dogs are Cystoisospora canis, Cystoisospora ohioensis (complex including C. ohioensis, C. burrowsi, C. neorivolta), and Cystoisospora rivolta. In cats, the main species are Cystoisospora felis and Cystoisospora rivolta. These coccidia are host-specific, with dogs and cats being the definitive hosts. Other coccidian parasites that can cause enteritis include Cryptosporidium spp. (e.g., C. parvum, C. felis, C. canis), which are zoonotic and more commonly associated with immunocompromised hosts, and Hammondia heydorni (in dogs) and Besnoitia spp., which are less pathogenic. Eimeria species are primarily pathogens of livestock and are rarely clinically significant in dogs and cats. The life cycle begins when a susceptible host ingests sporulated oocysts from a contaminated environment. In the small intestine, sporozoites are released, invade enterocytes, and undergo asexual multiplication (merogony), producing merozoites that infect adjacent cells. After several generations, gametogony occurs, forming microgametes and macrogametes; fertilization results in unsporulated oocysts that are shed in feces. Oocysts sporulate in the environment under favorable conditions (warmth, humidity, oxygen) within 1–5 days, becoming infective. Transmission is fecal-oral, often through ingestion of contaminated food, water, or fomites, or through coprophagy. Paratenic hosts (e.g., rodents) can also transmit Cystoisospora by harboring tissue cysts, which are infective when ingested by the definitive host.

Coccidiosis is distributed worldwide, with a higher prevalence in tropical and subtropical regions and in environments with poor sanitation. In dogs and cats, the infection is most common in puppies and kittens, particularly those under six months of age, due to their immature immune systems. Breed predilections are not well-defined, but stress, overcrowding, and poor hygiene in kennels, shelters, and breeding facilities significantly increase transmission rates. The prevalence of Cystoisospora spp. in shelter dogs has been reported to range from 10% to 50%, with higher rates in young animals. In cats, similar prevalence rates are observed. Cryptosporidium spp. are also common, with a prevalence of 5–15% in diarrheic dogs and cats, and higher in immunocompromised individuals. Seasonal patterns may occur, with increased shedding in warm, humid months when oocyst sporulation is optimal. The infection is self-limiting in immunocompetent adults, but can cause severe disease in neonates, and chronic shedding can occur in stressed or immunosuppressed animals. Zoonotic potential exists for Cryptosporidium, but Cystoisospora species are not considered zoonotic.

The pathophysiology of coccidiosis is primarily due to the intracellular replication of the parasite within the intestinal epithelium, leading to mechanical destruction of enterocytes and subsequent inflammatory responses. After ingestion of sporulated oocysts, sporozoites excyst in the small intestine and invade enterocytes, particularly in the ileum and jejunum. Asexual reproduction (merogony) causes lysis of host cells, leading to villous atrophy, crypt hyperplasia, and fusion of villi. This results in a reduced absorptive surface area, leading to malabsorption and osmotic diarrhea. The destruction of enterocytes also disrupts the integrity of the intestinal barrier, allowing for the translocation of bacteria and toxins, which can exacerbate inflammation. The host immune response, involving both innate and adaptive mechanisms, contributes to the pathology. Infiltration of neutrophils, macrophages, and lymphocytes occurs, and the release of pro-inflammatory cytokines (e.g., TNF-α, IL-1, IL-6) leads to further tissue damage. In severe cases, hemorrhage occurs due to erosion of the lamina propria. The infection can also lead to secondary bacterial overgrowth, sepsis, and electrolyte imbalances. In immunocompromised animals, the infection can become chronic and more severe, with extraintestinal spread (e.g., to mesenteric lymph nodes) in rare cases. Cryptosporidium spp. primarily infect the microvilli of enterocytes, causing villous atrophy and mild inflammation, but can cause severe, persistent diarrhea in immunodeficient hosts.

Several factors predispose dogs and cats to clinical coccidiosis. Age is the most significant; neonates and young animals (<6 months) are highly susceptible due to their naïve immune systems. Stressful conditions such as weaning, transportation, overcrowding, and environmental changes can precipitate clinical disease in subclinically infected animals. Poor sanitation and high oocyst contamination in the environment increase the infectious dose and likelihood of disease. Concurrent infections with other enteric pathogens (e.g., canine parvovirus, feline panleukopenia, Giardia, Salmonella) can exacerbate the severity of coccidiosis. Immunosuppression, whether due to viral infections (e.g., feline leukemia virus, feline immunodeficiency virus), chemotherapy, or corticosteroid therapy, increases susceptibility and severity. Malnutrition and poor body condition can impair immune responses. Certain management practices, such as group housing in shelters or kennels, facilitate fecal-oral transmission. In addition, coprophagy and ingestion of paratenic hosts (e.g., rodents) can increase exposure. Genetic factors may play a role in susceptibility, but specific breed predispositions are not well-documented.

Clinical signs of coccidiosis vary depending on the age and immune status of the animal, the parasite load, and the species involved. In peracute cases, especially in puppies and kittens, sudden death may occur without premonitory signs. Acute cases typically present with watery or mucoid diarrhea, which may progress to hemorrhagic diarrhea with frank blood. Affected animals may show tenesmus, flatulence, and abdominal discomfort. Systemic signs include lethargy, depression, anorexia, weight loss, and dehydration. Vomiting may occur, particularly in severe cases. Fever is variable but can be present. On physical examination, patients may be dehydrated, have poor body condition, and exhibit signs of abdominal pain on palpation. In chronic or subclinical cases, animals may have intermittent soft stools, poor growth, and a dull hair coat. Extraintestinal signs are rare but can occur in immunocompromised animals, with respiratory or neurological signs if the parasite disseminates. In cats, infection with Cystoisospora felis can cause similar signs, but may also be associated with ocular and respiratory signs in severe cases. Cryptosporidiosis often causes self-limiting diarrhea in immunocompetent animals, but can lead to chronic, profuse, watery diarrhea in immunocompromised hosts.

The differential diagnoses for coccidiosis include other causes of acute or chronic diarrhea in young dogs and cats. Key differentials include: 1) Canine parvovirus (CPV) infection: presents with severe hemorrhagic diarrhea, vomiting, leukopenia, and high morbidity; diagnosis via fecal ELISA or PCR. 2) Feline panleukopenia (feline parvovirus): similar to CPV, with severe leukopenia and high mortality in kittens; diagnosed by fecal PCR or ELISA. 3) Giardiasis: caused by Giardia duodenalis, presents with acute or chronic diarrhea, steatorrhea, and weight loss; diagnosis via fecal antigen ELISA or direct smear. 4) Bacterial enteritis (e.g., Salmonella, Campylobacter, Clostridium perfringens): can cause diarrhea, fever, and systemic signs; diagnosed via fecal culture or PCR. 5) Intestinal parasitism (e.g., hookworms, roundworms, whipworms): can cause diarrhea and failure to thrive; diagnosed via fecal flotation. 6) Dietary indiscretion or sudden diet change: can cause acute diarrhea, but typically resolves with supportive care and no infectious etiology. 7) Inflammatory bowel disease (IBD): chronic diarrhea, vomiting, and weight loss in older animals; diagnosed via intestinal biopsy. 8) Exocrine pancreatic insufficiency (EPI): chronic diarrhea, steatorrhea, and weight loss; diagnosed via serum TLI (trypsin-like immunoreactivity). 9) Intestinal intussusception: acute onset of vomiting, abdominal pain, and palpable abdominal mass; diagnosed via ultrasound or contrast radiography. 10) Toxin exposure (e.g., garbage ingestion, certain plants): can cause acute gastroenteritis; history is key. Definitive diagnosis of coccidiosis is made by identification of oocysts in feces via fecal flotation or direct smear, or by PCR.

The diagnostic approach to a suspected case of coccidiosis should follow a systematic algorithm. Step 1: Obtain a thorough history, including age, vaccination status, environment, diet, and potential exposure to other animals. Step 2: Perform a complete physical examination, with emphasis on hydration status, body condition, and abdominal palpation. Step 3: Collect a fresh fecal sample for parasitological examination. Perform fecal flotation using a centrifugal flotation technique with a sugar or zinc sulfate solution (specific gravity 1.18–1.20) to concentrate oocysts. Examine the sample microscopically for the presence of oocysts, which are typically 10–30 μm in diameter and may contain sporocysts. Direct smears can also be used for rapid identification, but are less sensitive. Step 4: If coccidia are identified, assess the severity of clinical signs and hydration status. Step 5: In cases with severe diarrhea, systemic signs, or suspected concurrent infections, perform additional diagnostics: complete blood count (CBC), serum biochemistry profile, and fecal PCR panel for enteric pathogens (e.g., parvovirus, Giardia, Salmonella, Campylobacter). Step 6: If the animal is not responding to treatment or if chronic diarrhea persists, consider abdominal imaging (radiographs, ultrasound) to rule out other causes, and possibly intestinal biopsy for histopathology. Step 7: In immunocompromised animals or those with suspected cryptosporidiosis, perform specific testing for Cryptosporidium (e.g., acid-fast staining, antigen ELISA, or PCR). Step 8: Based on the diagnostic findings, initiate appropriate therapy and supportive care. The gold standard for diagnosis is the identification of oocysts in feces, but PCR is more sensitive and can differentiate species.

Laboratory findings in coccidiosis are often nonspecific but can support the diagnosis and assess the severity of disease. Complete blood count (CBC) may reveal mild to moderate leukocytosis due to stress or inflammation, or leukopenia in cases of concurrent viral infections. Anemia may be present in chronic cases due to blood loss or malnutrition. Serum biochemistry profile may show dehydration (elevated total protein, albumin, and packed cell volume), electrolyte imbalances (hypokalemia, hyponatremia) due to diarrhea, and acid-base disturbances (metabolic acidosis). In severe cases, azotemia may occur due to prerenal causes. Fecal examination is the most important laboratory test: fecal flotation will reveal oocysts, which are characteristic. In cases of cryptosporidiosis, modified acid-fast staining of fecal smears can identify the acid-fast oocysts. Fecal antigen tests (ELISA) for Cryptosporidium and Giardia are available and can be used in combination. PCR assays for Cystoisospora and Cryptosporidium are highly sensitive and specific and can be used for species identification. In chronic cases, measurement of serum cobalamin and folate levels may be indicated to assess intestinal function, but these are not specific for coccidiosis. Additional tests may be warranted to rule out concurrent infections, such as parvovirus ELISA or PCR.

Imaging findings in coccidiosis are generally nonspecific and are primarily used to rule out other causes of diarrhea or to assess for complications. Abdominal radiographs may show gas-filled loops of small intestine, consistent with enteritis, but are not diagnostic. In severe cases, there may be evidence of fluid-filled bowel loops. Ultrasonography may reveal thickened intestinal walls, increased echogenicity of the mucosa, and hypermotility, but these findings are also seen in other enteritides. In cases of intussusception, ultrasound can identify the characteristic 'target sign'. Computed tomography (CT) is rarely indicated but may be used to evaluate for extraintestinal dissemination in immunocompromised animals. Endoscopy can be performed to visualize the intestinal mucosa and obtain biopsies, but is not routinely necessary for diagnosis. Imaging is most useful in ruling out mechanical obstructions or other structural abnormalities, and in monitoring for complications such as perforation or peritonitis in severe cases.

Cytological and histopathological findings in coccidiosis are characteristic when the parasite is identified in tissue samples. On cytological examination of fecal smears or intestinal aspirates, oocysts may be seen, but they are more commonly identified in fecal flotation. Histopathology of intestinal biopsies (obtained via endoscopy or at necropsy) reveals the presence of coccidian stages (meronts, gamonts, oocysts) within enterocytes, particularly in the small intestine. The lamina propria may show infiltration with neutrophils, lymphocytes, and plasma cells. Villous atrophy, crypt hyperplasia, and epithelial necrosis are common findings. In severe cases, there may be hemorrhage and ulceration. Special stains, such as Giemsa or periodic acid-Schiff (PAS), can highlight the parasites. For Cryptosporidium, organisms are seen attached to the microvillus border of enterocytes and are best visualized with acid-fast stains or immunohistochemistry. Histopathology is not typically required for diagnosis but is useful in chronic or atypical cases, or to rule out other causes of inflammatory bowel disease.

The treatment of coccidiosis involves both specific antiprotozoal therapy and supportive care. The primary drug used is sulfadimethoxine (Albon), a sulfonamide antibiotic with anticoccidial activity. The recommended dosage for dogs and cats is 55 mg/kg orally once daily on the first day, followed by 27.5 mg/kg orally once daily for 5–9 days. Alternatively, a dose of 50 mg/kg on day 1, then 25 mg/kg every 24 hours for 5–7 days is used. Sulfadimethoxine is effective against Cystoisospora but is not effective against Cryptosporidium. For cryptosporidiosis, treatment is more challenging; supportive care is the mainstay, and drugs such as azithromycin (10 mg/kg orally every 12 hours for 5–7 days) or paromomycin (150–250 mg/kg orally every 12 hours for 5 days) may be used, but efficacy is variable. Toltrazuril (Baycox) is another anticoccidial drug that can be used off-label in dogs and cats at a dose of 10–30 mg/kg orally once daily for 1–3 days, or as a single dose of 20 mg/kg. Ponazuril (Marquis paste) is a metabolite of toltrazuril and is used at a dose of 20–50 mg/kg orally once daily for 1–3 days. These drugs are often used in shelter settings for mass treatment. Supportive care includes fluid therapy to correct dehydration and electrolyte imbalances, using isotonic crystalloids (e.g., lactated Ringer's solution) at maintenance rates (60–100 ml/kg/day for puppies and kittens) or higher if dehydrated. Nutritional support is important; a highly digestible diet (e.g., Hill's i/d, Royal Canin Gastrointestinal) is recommended. Probiotics may be beneficial to restore normal gut flora. In severe cases, antiemetics (e.g., maropitant 1 mg/kg SC once daily) and antidiarrheals (e.g., loperamide 0.1 mg/kg PO q8h, but avoid in collies and other breeds with MDR1 mutation) may be used. Antibiotics are not indicated unless there is evidence of secondary bacterial infection. In immunocompromised animals, treatment may need to be prolonged, and addressing the underlying cause of immunosuppression is critical. Environmental decontamination is essential to prevent reinfection; oocysts are resistant to many disinfectants, but steam cleaning and 10% ammonia solution can be effective.

The prognosis for coccidiosis is generally excellent in immunocompetent animals with appropriate treatment and supportive care. Most animals recover within 1–2 weeks, and clinical signs resolve within a few days of initiating therapy. However, in neonates, severely debilitated animals, or those with concurrent infections, the prognosis is guarded, and mortality can be high if dehydration and malnutrition are not aggressively managed. Chronic or recurrent infections may occur in immunocompromised animals, and these individuals may require long-term management. Negative prognostic indicators include severe dehydration, hypothermia, hypoglycemia, and the presence of concurrent viral infections (e.g., parvovirus). With prompt and appropriate therapy, the prognosis is good, but without treatment, severe cases can be fatal. Reinfection is possible if environmental contamination is not addressed.

Follow-up care for animals with coccidiosis is important to ensure complete resolution and to prevent recurrence. Recheck fecal examinations should be performed 1–2 weeks after completion of treatment to confirm the absence of oocysts. If oocysts are still present, a second course of treatment may be necessary. Clinical signs should be monitored, and if diarrhea persists, further diagnostic workup is warranted to rule out other causes. For animals in shelters or kennels, environmental cleaning and disinfection protocols should be implemented, and new animals should be quarantined and screened for coccidia. In immunocompromised animals, long-term monitoring may be required, and periodic fecal examinations are recommended. Nutritional support should be continued until the animal is eating well and gaining weight. Owners should be educated about the importance of hygiene, proper disposal of feces, and preventing coprophagy. In multi-pet households, all animals may need to be treated if they are exposed, even if asymptomatic.

Pearls: 1) Coccidiosis is most common in puppies and kittens, especially in stressful environments like shelters; always consider it in young animals with diarrhea. 2) Fecal flotation is the most reliable diagnostic test; oocysts are often present in high numbers, but may be intermittent, so repeat testing may be needed. 3) Sulfadimethoxine is the first-line treatment and is safe in young animals; it is bacteriostatic and works by inhibiting folic acid synthesis in the parasite. 4) Toltrazuril and ponazuril are excellent alternatives, often requiring only a single dose, which is advantageous in shelter settings. 5) Always treat concurrent infections and provide aggressive supportive care, especially fluid therapy, to prevent dehydration. 6) Environmental decontamination is crucial; oocysts are highly resistant, and steam cleaning or 10% ammonia is effective. Pitfalls: 1) Do not use sulfadimethoxine in animals with a known hypersensitivity to sulfonamides; it can cause keratoconjunctivitis sicca (dry eye) in dogs, so monitor tear production if used long-term. 2) Avoid using loperamide in collies, Shelties, and other breeds with the MDR1 gene mutation, as it can cause severe neurological toxicity. 3) Do not rely solely on antiprotozoal therapy; supportive care is essential for recovery. 4) Do not assume that the presence of oocysts is the sole cause of diarrhea; always rule out other pathogens, especially parvovirus, in unvaccinated puppies. 5) Be aware that Cryptosporidium is not effectively treated with sulfadimethoxine; if suspected, use appropriate drugs or focus on supportive care. 6) Do not forget to treat all in-contact animals, as they may be subclinically infected and serve as a source of reinfection.

Based on Plumb's Veterinary Drug Handbook, the following drug protocols are recommended for coccidiosis in dogs and cats: 1) Sulfadimethoxine (Albon): Dogs and cats: 55 mg/kg PO on day 1, then 27.5 mg/kg PO q24h for 5–9 days. Alternatively, 50 mg/kg PO on day 1, then 25 mg/kg PO q24h for 5–7 days. It is contraindicated in animals with sulfonamide hypersensitivity, and caution is advised in animals with hepatic or renal impairment. It may cause crystalluria, so adequate hydration is important. 2) Toltrazuril (Baycox): Off-label use in dogs and cats: 10–30 mg/kg PO once daily for 1–3 days, or a single dose of 20 mg/kg. It is not approved in the US for dogs and cats, but is used in Europe and other regions. It is generally well-tolerated, but may cause mild gastrointestinal upset. 3) Ponazuril (Marquis paste): Off-label use in dogs and cats: 20–50 mg/kg PO once daily for 1–3 days. It is a paste formulation for horses, but is often used in shelter medicine. It is well-tolerated, but may cause mild diarrhea. 4) For Cryptosporidiosis: Azithromycin: 10 mg/kg PO q12h for 5–7 days; Paromomycin: 150–250 mg/kg PO q12h for 5 days (use with caution due to potential nephrotoxicity and ototoxicity); Nitazoxanide: 25 mg/kg PO q12h for 3–7 days (not commonly used in veterinary medicine). 5) Supportive care: Fluid therapy with isotonic crystalloids (e.g., LRS) at rates to correct dehydration (e.g., 5–8% dehydration: administer deficit over 4–6 hours, then maintenance 60–100 ml/kg/day). Electrolyte supplementation (potassium chloride 20–40 mEq/L in fluids) as needed. Antiemetics: Maropitant (Cerenia) 1 mg/kg SC q24h or 2 mg/kg PO q24h. Antidiarrheals: Loperamide (Imodium) 0.1 mg/kg PO q8h, but avoid in MDR1 mutant breeds; use with caution in cats. Probiotics (e.g., FortiFlora) can be given. Nutritional support: highly digestible diet, small frequent meals. In severe cases, hospitalization with IV fluids and monitoring is recommended.

Evidence-based literature on coccidiosis in dogs and cats is limited, but several studies provide guidance. A study by Lappin et al. (2017) evaluated the efficacy of ponazuril for the treatment of coccidiosis in shelter cats and found that a single dose of 50 mg/kg was effective in reducing oocyst shedding. Another study by Mitchell et al. (2016) compared sulfadimethoxine and toltrazuril in naturally infected puppies and found both to be effective, but toltrazuril required fewer doses. The ACVIM consensus statement on the diagnosis and treatment of enteric protozoal infections (Lappin et al., 2016) recommends sulfadimethoxine as the first-line treatment for Cystoisospora, with toltrazuril or ponazuril as alternatives. For Cryptosporidium, the consensus statement emphasizes supportive care and notes that no drug is consistently effective, but azithromycin or paromomycin may be considered. A study by Scorza et al. (2011) evaluated the prevalence of Cryptosporidium in shelter cats and found a high prevalence, highlighting the importance of screening. Additionally, a study by Gates et al. (2014) demonstrated that environmental decontamination with 10% ammonia or steam cleaning is effective in killing oocysts. Overall, the literature supports the use of sulfadimethoxine or toltrazuril/ponazuril for coccidiosis, with aggressive supportive care being critical for recovery.